Literature DB >> 31127765

Rate of Cognitive Decline in Alzheimer's Disease Stratified by Age.

Karen Stanley1,2, Tim Whitfield1,2, Karoline Kuchenbaecker2,3, Oliver Sanders1, Tim Stevens1, Zuzana Walker1,2.   

Abstract

BACKGROUND: There is only limited information available about the effect of age on course of cognitive decline in patients with onset of Alzheimer's disease (AD) over the age of 64 years.
OBJECTIVE: We compared the rate of, and factors affecting, cognitive decline in patients with AD aged < 65 years (young-onset AD), 65-74 years (middle-onset AD), and ≥75 years (late-onset AD).
METHOD: The study used longitudinal data from the Essex Memory Clinic which included a total of 305 participants; 56 had YOAD, 73 had MOAD, and 176 had LOAD. The rate of cognitive decline was measured using scores from the Mini-Mental State Examination (MMSE), and the data were examined using multilevel models analysis.
RESULTS: There was evidence of a difference in cognitive decline across the age groups with the YOAD group declining 2.8 MMSE points per year, those with MOAD declined 2.0 MMSE points per year, and the LOAD group declined 1.4 MMSE points per year.
CONCLUSIONS: Patients with LOAD have a better prognosis than YOAD and MOAD. However, even between the MOAD and LOAD groups, age is a significant predictor of cognitive decline, with older patients having a more benign course.

Entities:  

Keywords:  Alzheimer’s disease; cognitive decline; dementia; rate of decline; young-onset

Year:  2019        PMID: 31127765     DOI: 10.3233/JAD-181047

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Donepezil Treatment for Alzheimer's Disease in Chronic Dialysis Patients.

Authors:  Konstantina G Yiannopoulou; Aikaterini I Anastasiou; Andreas Kyrozis; Ioannis P Anastasiou
Journal:  Case Rep Nephrol Dial       Date:  2019-09-05

2.  Memory Complaint Is a Surrogate for Memory Decline in the Middle-Aged: A Register-Based Study.

Authors:  Yah-Yuan Wu; Wen-Chuin Hsu; Yu-Hua Huang; Wei-Min Ho; Yi-Chun Chen
Journal:  J Clin Med       Date:  2019-11-07       Impact factor: 4.241

3.  Increase in Frailty in Nursing Home Survivors of Coronavirus Disease 2019: Comparison With Noninfected Residents.

Authors:  Giada Ida Greco; Marianna Noale; Caterina Trevisan; Giancarlo Zatti; Martino Dalla Pozza; Martina Lazzarin; Labjona Haxhiaj; Roberto Ramon; Alessandra Imoscopi; Stefano Bellon; Stefania Maggi; Giuseppe Sergi
Journal:  J Am Med Dir Assoc       Date:  2021-02-22       Impact factor: 4.669

4.  Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer's Disease.

Authors:  Farida Dakterzada; Iván David Benítez; Adriano Targa; Albert Lladó; Gerard Torres; Leila Romero; David de Gonzalo-Calvo; Anna Moncusí-Moix; Adria Tort-Merino; Raquel Huerto; Manuel Sánchez-de-la-Torre; Ferran Barbé; Gerard Piñol-Ripoll
Journal:  Front Aging Neurosci       Date:  2021-08-23       Impact factor: 5.750

5.  Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia.

Authors:  Marco Zuin; Antonio Cherubini; Stefano Volpato; Luigi Ferrucci; Giovanni Zuliani
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.